Unbound MEDLINE

Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis. Clinical and laboratory haematology. [Clin Lab Haematol] Journal article

 
TitleHeterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis.
Author(s)Pathare A, Alkindi S, Albalushi T, Bayoumi R, Dennison D, Muralitharan S 
InstitutionDepartment of Haematology, College of Medicine, Sultan Qaboos University Hospital, Muscat, Sultante of Oman.
SourceClin Lab Haematol 2004 Apr; 26(2):143-6.
MeSHAdult
Arterial Occlusive Diseases
Erythrocytes
Folic Acid
Heterozygote
Humans
Hyperhomocysteinemia
Iliac Vein
Male
Methylenetetrahydrofolate Reductase (NADPH2)
Mutation
Popliteal Vein
Vena Cava, Inferior
Venous Thrombosis
Vitamin B 12
AbstractHyperhomocysteinemia is known to be associated with arterial occlusive vascular disease and venous thrombosis. Here, we report a young ethnic Omani patient with recurrent venous thrombosis who was found to be heterozygous for 677C-T mutation in the methyltetrahydrofolate reductase (MTHFR) enzyme. Moderate hyperhomocystenemia was also observed, in the presence of normal red cell folate and serum B12 levels. No other documented marker of hereditary thrombophilia could be demonstrated in this patient, in spite of extensive investigation on multiple occasions.
Languageeng
Pub Type(s)Case Reports
Journal Article
PubMed ID15053809
  
Advertise on this site.